Metraipolis › archive › dc_3076d3bb2b9b

Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study — Europe PMC PMID:40927528

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40927528
DOI
10.3389/fonc.2025.1634892
License (as archived)
solo-consultazione
Archived
2026-11-10T08:37:27.788Z
SHA-256 of the archived text
c53ef960bd7d0bb131b99e7f81564bc6b38111a42d3c520b6df730b5ef01ca86
Stable URL of this page
https://metraipolis.com/documento/dc_3076d3bb2b9b

How to cite

Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study — Europe PMC PMID:40927528 — Europe PMC (en), https://europepmc.org/article/MED/40927528 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3076d3bb2b9b (Metraipolis archive dc_3076d3bb2b9b, sha256 c53ef960bd7d0bb131b99e7f81564bc6b38111a42d3c520b6df730b5ef01ca86)
BibTeX
@misc{dc3076d3bb2b9b,
  title = {Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study — Europe PMC PMID:40927528},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40927528},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3076d3bb2b9b; sha256 c53ef960bd7d0bb131b99e7f81564bc6b38111a42d3c520b6df730b5ef01ca86},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40927528. Agents can read the archived copy with the MCP tool read_document.